Condition
Recurrent Pleural Malignant Mesothelioma|Stage IV Pleural Mesothelioma
Estimated Enrollment: 55
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: No masking|Primary Purpose: Treatment
Study ID Numbers: 2015-010|NCI-2015-01412|1506014121|P30CA022453
Study First Received: October 2, 2015
Last Updated: March 28, 2017
Estimated Primary Completion Date: January 1, 2018
Primary Outcome Measures:
Progression-free survival (PFS)|Incidence of grade 3-4 toxicity rate|Overall survival|Response rate (complete and partial response)
Sponsors and Collaborators:
Barbara Ann Karmanos Cancer Institute|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT02568449
